Fresenius Medical Care (FME Stock) provides a long-term opportunity
Premium|Take advantage of 50% OFF on your first month.
Start your subscription and get access to all our original articles.
You have reached your limit of 5 free articles for this month.
Get all exclusive analysis, access our analysis and get Gold and signals alerts
Elevate your trading Journey.
UPGRADEFresenius Medical Care is a German healthcare company. It is one of the four divisions of Fresenius SE & Co. KGaA. The company provides kidney dialysis services and treats end-stage renal disease. Today, it has a 38% share of the dialysis market in the US. Fresenius Medical Care operates 45 production sites, mainly in the US, Germany, and Japan. Founded in 1996 and headquartered in Bad Homburg vo rder Höhe, Germany, Fresenius Medical Care is a part of the DAX40 index. One can trade it under the ticker $FME at XETRA.
Fresenius Medical Care monthly Elliott Wave analysis 10.18.2021
The monthly chart below shows the Fresenius Medical Care stock $FME traded at XETRA. From all-time lows, the stock price has developed an Elliott wave motive wave pattern. The cycle up in black wave ((I)) being of grand supercycle degree has ended by printing its top at all-time highs in February 2018 at 93.82. Within the grand supercycle ((I)), the blue wave (III) of supercycle degree is an impulse showing an extension as related to the waves (I) and (V).
From the February 2018 high, a consolidation has started and is still in progress. First, a cycle lower in 3 waves has ended in January 2019. Then, from the 55.44 low a rally has failed to make a new high. After 3 waves of blue wave (x) ending in February 2020 at 81.10, $FME has broken below 55.44 low. As a matter of fact, this has opened a bearish sequence. As a consequence, while the price holds below 81.10, one should expect $FME to trade lower into the 42.67-18.87 area.
Investors and traders can buy Fresenius medical care from 42.67-18.87 areas expecting a long-term rally to the new highs. The target in the black wave ((III)) will be towards 136-194 areas in case of reaction from the 42.67 level.
Fresenius Medical Care is a German healthcare company. It is one of the four divisions of Fresenius SE & Co. KGaA. The company provides kidney dialysis services and treats end-stage renal disease. Today, it has a 38% share of the dialysis market in the US. Fresenius Medical Care operates 45 production sites, mainly in the US, Germany, and Japan. Founded in 1996 and headquartered in Bad Homburg vo rder Höhe, Germany, Fresenius Medical Care is a part of the DAX40 index. One can trade it under the ticker $FME at XETRA.
Fresenius Medical Care monthly Elliott Wave analysis 10.18.2021
The monthly chart below shows the Fresenius Medical Care stock $FME traded at XETRA. From all-time lows, the stock price has developed an Elliott wave motive wave pattern. The cycle up in black wave ((I)) being of grand supercycle degree has ended by printing its top at all-time highs in February 2018 at 93.82. Within the grand supercycle ((I)), the blue wave (III) of supercycle degree is an impulse showing an extension as related to the waves (I) and (V).
From the February 2018 high, a consolidation has started and is still in progress. First, a cycle lower in 3 waves has ended in January 2019. Then, from the 55.44 low a rally has failed to make a new high. After 3 waves of blue wave (x) ending in February 2020 at 81.10, $FME has broken below 55.44 low. As a matter of fact, this has opened a bearish sequence. As a consequence, while the price holds below 81.10, one should expect $FME to trade lower into the 42.67-18.87 area.
Investors and traders can buy Fresenius medical care from 42.67-18.87 areas expecting a long-term rally to the new highs. The target in the black wave ((III)) will be towards 136-194 areas in case of reaction from the 42.67 level.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.